Spectrum Pharmaceuticals, Inc.; Inc.;Spectrum Pharmaceuticals;University of Bradford
发明人:
Lenaz, Luigi,Phillips, Roger M.
申请号：
AU2007213476
公开号：
AU2007213476B2
申请日:
2007.02.09
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Disclosed herein are various bladder cancer treatments and methods. The presentdisclosure can take advantage of propylene glycol concentrations and/or NAD(P)H:quinoneoxidoreductase-1 (NQO1 ), Cytochrome P450 Oxidoreductase (P450R) and Glucosetransporter 1 (Glut-1 ) protein expression in human transitional cell carcinomaof the bladder to offer individually targeted bladder cancer treatments.
